Literature DB >> 33450892

Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features.

Mario Mietzsch1, Ariana Jose1, Paul Chipman1, Nilakshee Bhattacharya2, Nadia Daneshparvar2, Robert McKenna1, Mavis Agbandje-McKenna1.   

Abstract

The capsid structures of most Adeno-associated virus (AAV) serotypes, already assigned to an antigenic clade, have been previously determined. This study reports the remaining capsid structures of AAV7, AAV11, AAV12, and AAV13 determined by cryo-electron microscopy and three-dimensional image reconstruction to 2.96, 2.86, 2.54, and 2.76 Å resolution, respectively. These structures complete the structural atlas of the AAV serotype capsids. AAV7 represents the first clade D capsid structure; AAV11 and AAV12 are of a currently unassigned clade that would include AAV4; and AAV13 represents the first AAV2-AAV3 hybrid clade C capsid structure. These newly determined capsid structures all exhibit the AAV capsid features including 5-fold channels, 3-fold protrusions, 2-fold depressions, and a nucleotide binding pocket with an ordered nucleotide in genome-containing capsids. However, these structures have viral proteins that display clade-specific loop conformations. This structural characterization completes our three-dimensional library of the current AAV serotypes to provide an atlas of surface loop configurations compatible with capsid assembly and amenable for future vector engineering efforts. Derived vectors could improve gene delivery success with respect to specific tissue targeting, transduction efficiency, antigenicity or receptor retargeting.

Entities:  

Keywords:  AAV; capsid; cryo-EM; gene delivery; genome packaging; serotype

Mesh:

Substances:

Year:  2021        PMID: 33450892      PMCID: PMC7828300          DOI: 10.3390/v13010101

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.818


  76 in total

1.  Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity.

Authors:  N Kaludov; K E Brown; R W Walters; J Zabner; J A Chiorini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection.

Authors:  Yuji Kashiwakura; Kenji Tamayose; Kazuhisa Iwabuchi; Yukihiko Hirai; Takashi Shimada; Kunio Matsumoto; Toshikazu Nakamura; Masami Watanabe; Kazuo Oshimi; Hiroyuki Daida
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates.

Authors:  Lluis Samaranch; Ernesto A Salegio; Waldy San Sebastian; Adrian P Kells; John R Bringas; John Forsayeth; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2013-05-02       Impact factor: 5.695

4.  Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system.

Authors:  Hongwei Zhang; Bin Yang; Xin Mu; Seemin Seher Ahmed; Qin Su; Ran He; Hongyan Wang; Christian Mueller; Miguel Sena-Esteves; Robert Brown; Zuoshang Xu; Guangping Gao
Journal:  Mol Ther       Date:  2011-05-24       Impact factor: 11.454

5.  Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11.

Authors:  Lauriel F Earley; John M Powers; Kei Adachi; Joshua T Baumgart; Nancy L Meyer; Qing Xie; Michael S Chapman; Hiroyuki Nakai
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

6.  Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions.

Authors:  C Summerford; R J Samulski
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Impact of VP1-specific protein sequence motifs on adeno-associated virus type 2 intracellular trafficking and nuclear entry.

Authors:  Ruth Popa-Wagner; Manvi Porwal; Michael Kann; Matthias Reuss; Marc Weimer; Luise Florin; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

8.  Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity.

Authors:  Michael Schmidt; Antonis Voutetakis; Sandra Afione; Changyu Zheng; Danielle Mandikian; John A Chiorini
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

9.  Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach.

Authors:  L Patrick Havlik; Katherine E Simon; J Kennon Smith; Kelli A Klinc; Longping V Tse; Daniel K Oh; Marco M Fanous; Rita M Meganck; Mario Mietzsch; Jürgen Kleinschmidt; Mavis Agbandje-McKenna; Aravind Asokan
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

Review 10.  Twenty-Five Years of Structural Parvovirology.

Authors:  Mario Mietzsch; Judit J Pénzes; Mavis Agbandje-McKenna
Journal:  Viruses       Date:  2019-04-20       Impact factor: 5.048

View more
  8 in total

1.  Structural Study of Aavrh.10 Receptor and Antibody Interactions.

Authors:  Mario Mietzsch; Jennifer C Yu; Jane Hsi; Paul Chipman; Felix Broecker; Zhang Fuming; Robert J Linhardt; Peter H Seeberger; Regine Heilbronn; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2021-09-22       Impact factor: 5.103

Review 2.  Cryo-electron Microscopy of Adeno-associated Virus.

Authors:  Scott M Stagg; Craig Yoshioka; Omar Davulcu; Michael S Chapman
Journal:  Chem Rev       Date:  2022-05-16       Impact factor: 72.087

3.  Durable immunogenicity, adaptation to emerging variants, and low-dose efficacy of an AAV-based COVID-19 vaccine platform in macaques.

Authors:  Nerea Zabaleta; Urja Bhatt; Cécile Hérate; Pauline Maisonnasse; Julio Sanmiguel; Cheikh Diop; Sofia Castore; Reynette Estelien; Dan Li; Nathalie Dereuddre-Bosquet; Mariangela Cavarelli; Anne-Sophie Gallouët; Quentin Pascal; Thibaut Naninck; Nidhal Kahlaoui; Julien Lemaitre; Francis Relouzat; Giuseppe Ronzitti; Hendrik Jan Thibaut; Emanuele Montomoli; James M Wilson; Roger Le Grand; Luk H Vandenberghe
Journal:  Mol Ther       Date:  2022-05-10       Impact factor: 12.910

4.  Structurally Mapping Antigenic Epitopes of Adeno-associated Virus 9: Development of Antibody Escape Variants.

Authors:  Shanan N Emmanuel; J Kennon Smith; Jane Hsi; Yu-Shan Tseng; Matias Kaplan; Mario Mietzsch; Paul Chipman; Aravind Asokan; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2021-11-10       Impact factor: 6.549

Review 5.  AAV-mediated gene therapy: Advancing cardiovascular disease treatment.

Authors:  Huili Zhang; Qi Zhan; Biao Huang; Yigang Wang; Xiaoyan Wang
Journal:  Front Cardiovasc Med       Date:  2022-08-19

6.  Comparison of Different Liquid Chromatography-Based Purification Strategies for Adeno-Associated Virus Vectors.

Authors:  Ruth Rieser; Johanna Koch; Greta Faccioli; Klaus Richter; Tim Menzen; Martin Biel; Gerhard Winter; Stylianos Michalakis
Journal:  Pharmaceutics       Date:  2021-05-18       Impact factor: 6.321

Review 7.  Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry.

Authors:  Edward E Large; Mark A Silveria; Grant M Zane; Onellah Weerakoon; Michael S Chapman
Journal:  Viruses       Date:  2021-07-10       Impact factor: 5.048

8.  Receptor Switching in Newly Evolved Adeno-associated Viruses.

Authors:  L Patrick Havlik; Anshuman Das; Mario Mietzsch; Daniel K Oh; Jonathan Ark; Robert McKenna; Mavis Agbandje-McKenna; Aravind Asokan
Journal:  J Virol       Date:  2021-09-09       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.